Literature DB >> 11118640

Alternative glycosylation of the insulin receptor prevents oligomerization and acquisition of insulin-dependent tyrosine kinase activity.

J B Hwang, J Hernandez, R Leduc, S C Frost.   

Abstract

Glucose deprivation leads to the synthesis of an aberrantly glycosylated ('alternative') and inefficiently processed form of the insulin proreceptor in 3T3-L1 adipocytes. To further explore the effect of aberrant (rather than absent) N-linked glycosylation of the insulin receptor, we examined the relationship of processing to function. Our studies show that the alternative form of the proreceptor does not oligomerize nor does it acquire the ability to undergo insulin-sensitive autophosphorylation. This along with an interaction with the glucose-regulated stress protein GRP78/BiP implies inappropriate folding/dimerization and retention in the ER. Glucose refeeding causes the post-translational modification of the alternative form of the proreceptor to a novel 'intermediate' form which is independent of new protein synthesis. As little as 100 microM glucose (or mannose) can induce this modification. In vitro digestion of the alternative and intermediate proreceptors with SPC1/furin shows that both the alpha- and beta-subunit domains are glycosylated, albeit aberrantly. This implies that the aberrantly glycosylated proreceptor could serve as a substrate for SPC1 in a physiological setting if the receptor was able to interact with the enzyme in the appropriate compartment (i.e., the trans-Golgi network). Based on inhibitor studies, however, both the alternative and intermediate forms of the proreceptor appear to be primarily targeted to the proteasome for degradation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11118640     DOI: 10.1016/s0167-4889(00)00109-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

Review 1.  The roles of O-linked β-N-acetylglucosamine in cardiovascular physiology and disease.

Authors:  Natasha E Zachara
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-01-27       Impact factor: 4.733

Review 2.  Proprotein convertases in tumor progression and malignancy: novel targets in cancer therapy.

Authors:  Abdel-Majid Khatib; Géraldine Siegfried; Michel Chrétien; Peter Metrakos; Nabil G Seidah
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

3.  Calreticulin and Hsp90 stabilize the human insulin receptor and promote its mobility in the endoplasmic reticulum.

Authors:  Rowena R Ramos; Andrea J Swanson; Joseph Bass
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-11       Impact factor: 11.205

4.  Obesity resistance and deregulation of lipogenesis in Δ6-fatty acid desaturase (FADS2) deficiency.

Authors:  Wilhelm Stoffel; Ina Hammels; Britta Jenke; Erika Binczek; Inga Schmidt-Soltau; Susanne Brodesser; Margarete Odenthal; Mario Thevis
Journal:  EMBO Rep       Date:  2013-12-30       Impact factor: 8.807

5.  Regulation of Insulin Receptor Trafficking by Bardet Biedl Syndrome Proteins.

Authors:  Rachel D Starks; Andreas M Beyer; Deng Fu Guo; Lauren Boland; Qihong Zhang; Val C Sheffield; Kamal Rahmouni
Journal:  PLoS Genet       Date:  2015-06-23       Impact factor: 5.917

6.  A point mutation in the extracellular domain of KIT promotes tumorigenesis of mast cells via ligand-independent auto-dimerization.

Authors:  Yosuke Amagai; Akira Matsuda; Kyungsook Jung; Kumiko Oida; Hyosun Jang; Saori Ishizaka; Hiroshi Matsuda; Akane Tanaka
Journal:  Sci Rep       Date:  2015-05-12       Impact factor: 4.379

Review 7.  Identification and characterization of adipose surface epitopes.

Authors:  Yasuhiro Onogi; Ahmed Elagamy Mohamed Mahmoud Khalil; Siegfried Ussar
Journal:  Biochem J       Date:  2020-07-17       Impact factor: 3.857

8.  Neuraminidase 1 activates insulin receptor and reverses insulin resistance in obese mice.

Authors:  Anne Fougerat; Xuefang Pan; Victoria Smutova; Nikolaus Heveker; Christopher W Cairo; Tarik Issad; Bruno Larrivée; Jeffrey A Medin; Alexey V Pshezhetsky
Journal:  Mol Metab       Date:  2018-04-21       Impact factor: 7.422

9.  Positive regulation of insulin signaling by neuraminidase 1.

Authors:  Larbi Dridi; Volkan Seyrantepe; Anne Fougerat; Xuefang Pan; Eric Bonneil; Pierre Thibault; Allain Moreau; Grant A Mitchell; Nikolaus Heveker; Christopher W Cairo; Tarik Issad; Alexander Hinek; Alexey V Pshezhetsky
Journal:  Diabetes       Date:  2013-03-21       Impact factor: 9.461

Review 10.  Glycans as Regulatory Elements of the Insulin/IGF System: Impact in Cancer Progression.

Authors:  Julio Cesar M de-Freitas-Junior; Jéssica Andrade-da-Costa; Mariana Costa Silva; Salomé S Pinho
Journal:  Int J Mol Sci       Date:  2017-09-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.